Glucagon-like peptide-1 (GLP-1) receptor agonists have emerged as a potent class of drugs in the management of type 2 diabetes mellitus. These agents replicate the actions of naturally occurring GLP-1, promoting https://socials360.com/story10383610/new-glucagon-like-peptide-1-receptor-agonists-a-comprehensive-review